The expanding demand for specific immunological research and therapeutic design has spurred significant advances in recombinant cytokine manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently generated using various expression platforms, including prokaryotic hosts, mammalian cell populations, and vira